PIK3CA, BRAF, and PTEN Status and Benefit from Cetuximab in the Treatment of Advanced Colorectal Cancer-Results from NCIC CTG/AGITG CO.17

Christos Karapetis, Derek Jonker, Manijeh Daneshmand, Jennifer Hanson, Christopher O'Callaghan, Celia Marginean, John Zalcberg, R. Simes, Malcolm Moore, Niall Tebbutt, Timothy Price, Jeremy Shapiro, Nick Pavlakis, Peter Gibbs, Guy van Hazel, U Lee, Rashida Haq, Shakeel Virk, Dongsheng Tu, Ian Lorimer

    Research output: Contribution to journal › Article › peer-review

    147 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'PIK3CA, BRAF, and PTEN Status and Benefit from Cetuximab in the Treatment of Advanced Colorectal Cancer-Results from NCIC CTG/AGITG CO.17'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science

    Biochemistry, Genetics and Molecular Biology